Updates from the Pharmaceutical Benefits Advisory Committee (PBAC) 22 Dec 2017

The PBAC met in November this year to review the most recent applications for new drugs or amendments to the prescribing rules for existing drugs. Four myeloma drugs were reviewed during this meeting....